# Divergent Investments

Divergent Investments is a Private Equity based in Grand Duchy Of Luxembourg, Luxembourg.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Grand Duchy Of Luxembourg, Luxembourg
- **Region:** Europe
- **Address:** Luxembourg, Luxembourg
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** www.divergent-investments.com
- **LinkedIn:** https://www.linkedin.com/company/investdivergent

## Regulatory record

- **CRD number:** 327211
- **SEC file number:** 802-128593
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/327211

## About

Divergent Investments is a Data & AI-powered private equity fund that combines operational expertise with technology to systematize sourcing, underwriting, execution, growth and exits. It brands its approach as Private Equity 5.0, combining five pillars: Operational Execution, Market Intelligence, Data & AI, Responsible Investment, and Behavioral Science. The firm invests in healthspan themes within the new health economy, including preventive health, wellness and longevity, and animal and environmental health.

## Sectors

- Wellness & Longevity
- Sports
- Healthcare Services

## People

- Francis Bento — Founder & CEO
- Sabrina Colin — Chief Investment Officer
- Marc Le Corre — Chief Operating Officer & Chief Financial Officer
- Jean-Nicolas Pagnoux — Head of Market Intelligence

## Questions

### Who runs investment decisions at Divergent Investments?

Sabrina Colin serves as Chief Investment Officer, overseeing the full investment cycle from sourcing to exit. She works alongside CEO Francis Bento, who set the firm's strategic direction after leading the global private equity program at IKEA's investment arm. The entire investment committee is internal, drawing on operational and data specialists.

### How does Divergent Investments source proprietary deal flow?

The firm relies on its proprietary AI platform, including a tool called VISION, to systematize deal sourcing and due diligence. Founding partner and Head of Market Intelligence Jean-Nicolas Pagnoux also monitors sector trends and comparable listed companies to identify prospects. The data team analyzes fragmented information sets to surface opportunities overlooked by conventional managers.

### What investment stages does Divergent Investments target?

Divergent targets early-stage companies, including seed-stage operations, within the health economy. It only invests where it can actively add value through operational execution and its in-house data and behavioral science units, focusing on scalable businesses with high growth potential.

### Does Divergent Investments operate proprietary data tools?

Yes, the firm built a suite of tools integrating machine learning engineers and data scientists directly into the fund. VISION handles deal sourcing and diligence, SYNAPSE provides portfolio monitoring and lead generation, and LEAF models ESG risks. Portfolio company PTO's CEO has publicly credited Divergent with building the internal tools that unify the organization's fragmented data.

### Where does the founding team's experience originate?

CEO Francis Bento and CIO Sabrina Colin both spent over a decade at Inter Fund Management, the private investment office for Interogo Holding Group and the Inter-Ikea group. Bento led the global private equity program, investing across buyouts, growth, venture, and distressed strategies in North America, Europe, Latin America, Asia, and Africa.

### What thematic focus defines the portfolio?

The firm concentrates on the 'Healthspan' theme, targeting the $5 trillion new health economy. It invests across preventive health services, wellness and longevity products, and animal and environmental health initiatives. The current known portfolio includes the Professional Triathletes Organization, which falls under the wellness and longevity theme.

### Does Divergent Investments co-invest alongside external partners?

Yes, the firm participates in syndicated rounds. In the Professional Triathletes Organization's Series B and C financings, Divergent appeared alongside other known investors including Sir Michael Moritz (formerly of Sequoia Capital) and Warner Bros. Discovery.

## Related profiles

- [District Ventures Capital](https://altss.com/profile/district-ventures-capital)
- [DNA Partners](https://altss.com/profile/dna-partners)

---

Last updated: 2026-08-11T15:06:35.052Z

Canonical page: https://altss.com/profile/divergent-investments

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology
